case report aspiration during anesthesia glp-1 receptor agonist 2023 and Anesthesia: Considerations and Cautions for CRNAs American Society for Gastrointestinal Endoscopy

NHS availability is determined by NICE guidance, with specific criteria for diabetes and weight management indications requiring specialist assessment and monitoring

Frequently Asked Questions: What are GLP-1 receptor agonists (GLP-1 RAs)

Antibody cross-reactivity with native GIP and GLP-1 was seen in 40% and 16.5%, respectively

This result often outperforms many traditional weight-loss interventions, especially in patients with obesity

As Fig 3B reveals, I-M-150847 enhances GSIS in a dose-dependent manner, the increase is comparable to liraglutide at 100nM and 1M concentration at 30 minutes post-treatment with the agonists despite comparatively reduced cAMP accumulation upon I-M-150847 treatment

Although there are many ongoing large CVD outcome trials of GLP-1 RA treatment (Table 1), more simultaneous investigation of the causal relationship between GLP-1 RA administration and useful surrogate measures of CVD, including carotid IMT, would help us understand the potential mechanisms through which GLP-1 RAs may result in favorable cardiovascular outcomes in patients with T2D